Evidence map›Paper›PMID 33623804›Full record

ArticleOpen forum infectious diseases2021

Impact of Coronavirus Disease 2019 on Infectious Diseases Fellows in the United States: Perspectives From the First National Infectious Diseases Fellows Call.

Saman Nematollahi, Victoria J L Konold, David C Gaston, Jessica Howard-Anderson, John L Kiley, Mary C Masters, Michael T Melia, Gayle P Balba, Augusto Dulanto Chiang, Nupur Gupta

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Open forum infectious diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 99% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 8 institutions in 1 country.

Saman NematollahiDepartment of Medicine, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.ORCID https://orcid.org/0000-0002-6910-1120
Victoria J L KonoldDepartment of Pediatrics, Division of Infectious Diseases, University of Washington, Seattle, Washington, USA.
David C GastonDepartment of Pathology, Division of Microbiology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Jessica Howard-AndersonDepartment of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, Georgia, USA.
John L KileyDepartment of Medicine, Division of Infectious Diseases, Brooke Army Medical Center, Fort Sam Houston, Texas, USA.
Mary C MastersDepartment of Medicine, Division of Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Michael T MeliaDepartment of Medicine, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Gayle P BalbaDepartment of Medicine, Division of Infectious Diseases, Georgetown University Hospital, Washington, DC, USA.
Augusto Dulanto ChiangBacterial Pathogenesis and Resistance Unit, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Nupur GuptaDepartment of Medicine, Division of Infectious Diseases, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
Johns Hopkins University · USBrooke Army Medical Center · USEmory University · USGeorgetown University · USNational Institutes of Health · USNorthwestern University · USUniversity of Pittsburgh Medical Center · USUniversity of Washington · US

Funding

Antibacterial Resistance Leadership Group (ARLG)UM1AI104681 · NIAID · DUKE UNIVERSITY · PI Vance G. Fowler, Henry F HENRY CHAMBERS · 2013 to 2026
$180.8M
Longitudinal Trajectories of Physical and Cognitive Function among Persons Aging with HIVR03AG067980 · NIA · NORTHWESTERN UNIVERSITY AT CHICAGO · PI MASTERS, MARY CLARE · 2020 to 2021
$318k
NIAID NIH HHS UM1 AI104681NIA NIH HHS R03 AG067980
6 · The paper itself

Abstract

The coronavirus disease 2019 (COVID-19) pandemic has affected many providers, but its impact on Infectious Diseases (ID) fellows in the United States is largely undescribed. In this study, we discuss key issues that emerged from the first national ID Fellows Call with respect to the ID fellow's role during the COVID-19 pandemic, teaching/learning, and research.

Indexed as

COVID-19ID fellowship trainingpandemicpostgraduate medical education

Identifiers

PMID33623804
PMCPMC7888565
OpenAlexW3127179350

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.